EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-Analysis

Shao-Wen Zhang, Ru-hu Xu, Dan Chen

Digestive Diseases · 2023 · 41 (2) · 217-226

DOI: 10.1159/000526809 ↗
AbstractBibliografische Angaben

Abstract

Background and Objectives: Microscopic colitis (MC) is a chronic inflammatory bowel disease characterized by watery diarrhoea and a normal radiological and endoscopic appearance. Concern regarding a potential association between drug exposure and MC has recently emerged. We sought to systematically review and summarize the evidence for the potential association. Methods: A systematic review and meta-analysis were performed to evaluate the incidence of MC associated with exposure to drug. The PubMed and Embase databases were searched to identify potential studies for inclusion. Results: Twelve case-control studies were included in the meta-analysis. The results showed exposure to NSAID (OR, 1.64; 95% CI: 1.14–2.37; p < 0.001), PPI (OR, 2.36; 95% CI: 1.59–3.52; p < 0.001), SSRI (OR, 2.16; 95% CI: 1.5–3.13; p < 0.001), or aspirin (OR, 2.84; 95% CI: 1.4–5.76; p < 0.001) was related to the incidence of MC; however, such relationships in PPI and SSRI may be modulated by the selection of controls. Furthermore, we did not found a positive association with other drug exposure and MC. Conclusion: This meta-analysis indicated that NSAID, PPI, SSRI, or aspirin consumption may increase the risk for MC. Further studies exploring drug-induced microscopic colitis should include control groups with diarrhoea and not only healthy controls.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →